Macular pigment and its contribution to visual performance and experience;El pigmento macular y su contribución al rendimiento y experiencia visuals

Journal of Optometry

Volumn 3, Issue 2, 2010, Pages 74-90

  Loughman, James ^a   Davison, Peter A ^a   Nolan, John M ^b   Akkali, Mukunda C ^b   Beatty, Stephen ^b  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b South East Technological University   (Ireland)

Author keywords

Age related macular degeneration; Macular pigment; Optical hypothesis; Short wavelength light; Visual performance

Indexed keywords

EID: 77955346287     PISSN: 18884296     EISSN: 19891342     Source Type: Journal    
DOI: 10.1016/S1888-4296(10)70011-X     Document Type: Review

References (79)

1. Buzzi F. Nuove sperienze fatte sull' occhio umano. Opuscoli Scetti Sulle Scienze e Arti. 1782;5:87.
2. Home E. An account of the orifice in the retina of the human eye, discovered by Professor Soemmering. To which are added, proofs of this appearance being extended to the eyes of other animals. Philos Trans Roy Soc London. 1798;2:332.
3. Gullstrand A. Die farbe der macula centralis retinae. Albrecht von Graefes Arch Ophthalmol. 1906;62:1.
4. Schültze M. Sur la lache jaune de la retine at son influence sur la vue normale et sur les anomalies de la perception des coleurs (traduit par Leber). J d'Anat et de Physiol de Ch Robin. 1866; 440-6.
5. Shlaer S. The relation between visual acuity and illumination. J Gen Physiol. 1937;21:165-88.
6. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
7. Wong AM, Sharpe JA. Representation of the visual field in the human occipital cortex. Arch. Ophthalmol. 1999;117:208.
8. Horton JC, Hoyt WF. The representation of the visual field in human striate cortex. Arch Ophthalmol. 1991;109:816.
9. Kvansakul J, Rodriguez-Carmona M, Edgar DF. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthal Physiol Opt. 2006;26:362-71.
10. Howarth PA, Bradley A. The longitudinal chromatic aberration of the human eye and its correction. Vis Res. 1986;26:361-6.
11. Campbell FW, Gubisch RW. Optical quality of the human eye. J Physiol London. 1966;186:558-78.
12. Bradley A. Glenn A. Fry Award Lecture 1991: perceptual manifestations of imperfect optics in the human eye: attempts to correct for ocular chromatic aberration. Optom Vis Sci. 1992; 69:515-21.
13. Thibos LN, Bradley A, Zhang X. Effect of chromatic aberration on monocular visual performance. Optom Vis Sci. 1991;68: 599-607.
14. Wooten BR, Hammond BR. Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res. 2002;21:225-40.
15. Reading VM, Weale RA. Macular pigment and chromatic aberration. J Opt Soc Am. 1974;64:231-4.
16. Nussbaum JJ, Pruett RC, Delori FC. Historic perspectives: macular yellow pigment: the first 200 years. Retina. 1981;1:296-310.
17. Magnussen S, Spillman L, Sturzel F, Werner JS. Unveiling the foveal blue scotoma through an afterimage. Vis Res. 2004;44: 377-83.
18. Willmer EN. Color of small objects. Nature. 1944;153:774-5.
19. Parry NRA, Plainis S, Murray IJ, McKeefry DJ. Effect of foveal tritanopia on reaction times to chromatic stimuli. Visual Neuroscience. 2004;21:237-42.
20. Bone RA, Landrum JT. Dichroism of lutein: a possible basis for Haidinger's brushes. Appl. Opt. 1983;22:775-6.
21. Bone RA, Landrum JT. Macular pigment in henle fiber membranes: A model for Haidinger's brushes. Vis Res. 1998;24: 103-8.
22. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophth Vis Sci. 1997;38: 167-75.
23. Misson GP. Form and behaviour of Haidinger's brushes. Ophthal Physiol Opt. 1993;13:392-6.
24. Walls GL, Judd HD. The intraocular color filters of vertebrates. Br J Ophthalmol. 1932;17:641-705.
25. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vis Res. 1992;32:105-10.
26. Wald G. Blue-blindness in the normal fovea. J Opt Soc Am. 1967;57:1289-303.
27. Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Ret Eye Res. 2004;23:533-59.
28. International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to broad-band incoherent optical radiation (0.38 to 3 microns), Health Phys. 1997;73: 539-54.
29. Hemenger RP. Dichroism of the macular pigment and Haidinger's brushes. J Opt Soc Am. 1982;72:734-7.
30. Slatker JS, Stur M. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophth. 2005;50:263-273.
31. Wolffsohn JS, Cochrane AL, Khoo H, Yoshimitsu Y, Wu S. Contrast is enhanced by yellow lenses because of selective reduction of short wavelength light. Optom Vis Sci. 2000;77:73-81.
32. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry. 2000;71:147-64.
33. Aleman TS, Duncan JL, Bieber ML, De Castro E, Marks DA, Gardner LM, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873-81.
34. Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, Emmons JM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res. 2002;74:371-81.
35. Aleman TS, Cideciyan AV, Windsor AM, Schwartz SB, Swider M, Chico JD, et al. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci. 2007;48:1319-29.
36. Shaban H, Borras C, Vina J, Richter C. Phosphatidylglycerol potently protects human retinal pigment epithelial cells against apoptosis induced by A2E, a compound suspected to cause age-related macular degeneration. Exp Eye Res. 2002;75:99-108.
37. Seddon JM, Ajani UA, Sperduto R, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-20 [published correction appears in JAMA. 1995;273:622].
38. Nolan JM, Stack J, O'Donovan O, Loane E, Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84(1):61-74.
39. Loane E, Kelliher C, Beatty S, Nolan JM. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J. Ophthalmol. 2008;92:1163-68.
40. Richer S. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc. 1999;70:24-36.
41. Richer S, Stiles W, Laisvyde S. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:223-9.
42. Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology. 2003;110: 51-60.
43. Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomised controlled trial. Eur J Clin Nut. 2007;61: 1121-27.
44. Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S; CARMIS Study Group. Carotenoids and antioxidants in age-related maculopathy Italian study: Multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008;115: 324-33.
45. Olmedilla B, Granado F, Blanco I. Lutein, but not a-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition. 2003;19:21-4.
46. Stringham JM, Fuld K, Wenzel AJ. Action spectrum for photophobia. J Opt Soc Am. 2003;20:1852-8.
47. Wenzel AJ, Fuld K, Stringham JM, Curran-Celentano J. Macular pigment optical density and photophobia light threshold. Vis Res. 2006;46:4615-22.
48. Stringham JM, Hammond BR. The glare hypothesis of macular pigment function. Optom Vis Sci. 2007;84:859-64.
49. Stringham JM, Hammond BR. Macular pigment and visual performance under glare conditions. Optom Vis Sci. 2008;85:82-8.
50. Engles M, Wooten BR, Hammond BR. Macular pigment; A test of the acuity hypothesis. Invest Oph Vis Sci. 2007;48:2922-31.
51. Loughman J, Akkali MC, Beatty S, Scalon 6, Davidson PA, Nolan JM. The relationship between macular pigment and visual performance. Vision Res. 2010. [Epub ahead of print].
52. Bartlett HE, Eperjesi F. A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes. Clin Nutr. 2008;27: 218-27.
53. Hammond BR, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am. 1997;14:1187-96.
54. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-73.
55. Moreland JD, Dain SL. Macular pigment contributes to variance in 100 hue tests. Doc Ophthalmol 1995;57:517-22.
56. Hammond BR, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: Association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:397-406.
57. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A Opt Image Sci Vis. 2000;17: 1918-32.
58. Moreland JD, Westland S. Macular pigment: Nature's notch filter. In: Mollon JD, Pokorny J, Knoblauch K, editors. Norml and defective color vision. Oxford: Oxford University Press; 2003. p. 273-8.
59. Moreland JD, Westland S. Macular pigment and color discrimination. Vis Neurosci. 2006;23:549-54.
60. Rodriguez-Carmona M, Kvansakul J, Harlow J, et al. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and color vision. Ophthal Physiol Opt. 2006;26:137-47.
61. Stringham JM, Hammond BR. Compensation for light loss due to filtering by macular pigment: relation to hue cancellation. Ophthal Physiol Opt. 2007;27:232-7.
62. Muftuoglu O, Karel F, Duman R. Effect of a yellow intraocular lens on scotopic vision, glare disability, and blue color perception. J Cataract Refract Surg 2007;33:658-66.
63. Delahunt PB, Webster MA, Ma L, Werner JS. Long-term normalization of chromatic mechanisms following cataract surgery. Vis Neurosci 2004;21:301-7.
64. Neitz J, Carroll J, Yamauchi Y, Neitz M, Williams DR. Color perception is mediated by a plastic neural mechanism that is adjustable in adults. Neuron 2002;35:783-92.
65. Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vis Res. 1983;23:689-99.
66. Said FS, Weale RA. The variation with age of the spectral transmissivity of the living crystalline lens. Gerontologia. 1961;3:213-231.
67. Weale RA. The Senescence of Human Vision. New York: Oxford University Press; 1992. p. 79.
68. Hammond BR, Wooten BR, Snodderly DM. The density of the human crystalline lens in relation to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci. 1997;74: 499-504.
69. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nut. 1999;70:509-16
70. Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, Spiegelman D, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nut. 1999; 70:517-24.
71. Werner JS, Steele VG. Sensitivity of human foveal color mechanisms throughout the life span. J Opt Soc Am. 1988;5: 2122-30.
72. Haegerstrom-Portnoy G. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J Opt Soc Am. 1988;5:2140-4.
73. Schupp C, Estibaliz O-M, Gerth C, Morrissey BM, Cross CE, Werner JS. Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis. Am J Clin Nut. 2004;79: 1045-52.
74. Beatty S, Nolan J, Kavanagh H, O'Donovan O. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeazanthin. Arch Biochem Biophys. 2004; 430:70-6.
75. Hammond BR, Wooten BR. CFF thresholds: relation to macular pigment optical density. Ophthal Physiol Opt. 2005;25:315-9.
76. Yoon GY, Williams DR. Visual performance after correcting the monochromatic and chromatic aberrations of the eye. J Opt Soc Am. 2002;19:266-75.
77. Wild JM, Hudson C. The attenuation of blue-on-yellow perimetry by the macular pigment. Ophthalmology. 1995;102: 911-7.
78. Trieschmann M, Van Kuijk FJGM, Alexander R, Hermans P, Luthert P, Bird AC, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye. 2008;22:132-7.
79. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision beyond acuity. Optom Vis Sci. 1999;76:141-58.